Business
Kimberly-Clark closes its acquisition of Tylenol maker Kenvue. What to expect next
Kimberly-Clark has a plan improve growth and earnings following its acquisition of Kenvue
- Published
- (1 h ago)
- Outlet
- CNBC Top News
- Section
- Business
- Length here
- Headline and 13-word snippet. The full article is at the source.
More from CNBC Top News and around the same time
Feeling isolated? Half of in-office workers describe their desk jobs as 'remote,' NY Fed survey findsEmployees describing jobs as 'remote' are now often in-office, as companies fail to create the collaboration they claim is critical, NY Fed research shows.Palantir reports booming U.S. commercial revenue growth, topping government for first timePalantir's commercial revenue jumped 148% to $984 million, surpassing government revenue of $953 million.I bonds now pay 5.51% — but there are trade-offs. What to know before buyingI bonds are now paying 5.51%. Here are some key things to know before investing, according to financial experts.Trump focuses on Reflecting Pool in final public speech before midtermsTrump seemed to acknowledge that Democrats had an advantage heading into Election Day. "But we gave this a very strong shot," he said.Intel foundry push faces critical test after stock's 45% plunge in OctoberIntel’s turnaround now hinges on proving its foundry strategy can deliver, as customers look for signs the company will add fab capacity and catch TSMCPrediction market traders now see nearly 75% chance of Democrats winning the SenateJust a day before the midterms, Kalshi traders give Democrats a 74% of controlling the Senate.This page holds the headline and a short snippet as published by CNBC Top News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
